IL1B and cervical carcinoma: Although several polymorphisms in the genes encoding various interleukins have been described in relation to cervical carcinoma and its precursor lesions [59–63], the most consistently reported SNP is in the promotor region of the IL1B gene (c.-511C>T) encoding interleukin-1 beta (mediator of the inflammatory response, cell proliferation, differentiation, and apoptosis), which has been demonstrated to be associated with cervical carcinoma risk in Korean, North Indian, Chinese Han, and Egyptian populations [12–15].